Shaemus Gleason

Executive Vice President Clarity Pharmaceuticals

Seminars

Tuesday 11th November 2025
Strategies to Mitigate Isotope Supply Challenges for Actinium to Ensure Consistent Supply
11:00 am
  • Navigating reliance on decommissioned nuclear materials and government-controlled isotope stock
  • Exploring scalable actinium and terbium generation methods
  • How companies are hedging risk by contracting with multiple suppliers and monitoring delivery readiness
Shaemus Gleason, Executive Vice President, Clarity Pharmaceuticals